Aicardi–Goutières syndrome and the type I interferonopathies
The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Abstract
Dissection of the genetic basis of Aicardi-Goutières syndrome has highlighted a fundamental link between nucleic acid metabolism, innate immune sensors and type I interferon induction. This had led to the concept of the human interferonopathies as a broader set of Mendelian disorders in which a constitutive upregulation of type I interferon activity directly relates to disease pathology. Here, we discuss the molecular and cellular basis of the interferonopathies, their categorization, future treatment strategies and the insights they provide into normal physiology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ADAR edits Alu RNA51, and gain of function mutations in MDA5 suggest that RNA-sensing mechanisms are involved in some AGS cases119.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [119]
In the citing paper
“Aicardi–Goutières syndrome (AGS) is a childhood encephalopathy with similarities to SLE and strong IFN-I induction119.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [119]
In the citing paper
“In fact, hypocomplementia is a common feature of type I interferonopathies66,67”
From Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation (2017) · cites this paper as [66]
In the citing paper
“For example, deficits in RNASEH2, an enzyme responsible for removing ribonucleotides from DNA and resolving R‐loops, comprise more than half of AGS diagnoses (Crow & Manel, 2015).”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Crow & Manel, 2015
In the citing paper
“AGS is caused by mutations in genes that regulate nucleic acid metabolism.”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Crow & Manel, 2015
Citations
Cites
1 retracted
MAVS, cGAS, and endogenous retroviruses in T-independent B cell responses
Zeng, M., Hu, Z., Shi, X., Li, X., Zhan, X., Li, X.-D., Wang, J., Choi, J. H., Wang, K.-W., Purrington, T., et al. (2014) · Science · doi:10.1126/science.346.6216.1486 · Cited by 112
RetractedMitochondrial DNA stress primes the antiviral innate immune response
West, A. P., Khoury-Hanold, W., Staron, M., Tal, M. C., Pineda, C. M., Lang, S. M., Bestwick, M., Duguay, B. A., Raimundo, N., MacDuff, D. A., et al. (2015) · Nature · doi:10.1038/nature14156 · Cited by 1,975
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M. (2011) · Nature · doi:10.1038/nature10117 · Cited by 1,511
Activated STING in a Vascular and Pulmonary Syndrome
Liu, Y., Jesus, A. A., Marrero, B., Yang, D., Ramsey, S. E., Montealegre Sanchez, G. A., Tenbrock, K., Wittkowski, H., Jones, O. Y., Kuehn, H. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312625 · Cited by 1,412
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia
Landau, D. A., Carter, S. L., Stojanov, P., McKenna, A., Stevenson, K., Lawrence, M. S., Sougnez, C., Stewart, C., Sivachenko, A., Wang, L., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.019 · Cited by 1,379
Trex1 prevents cell-intrinsic initiation of autoimmunity
Stetson, D. B., Ko, J. S., Heidmann, T., & Medzhitov, R. (2008) · Cell · doi:10.1016/j.cell.2008.06.032 · Cited by 1,280
Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein
Hrecka, K., Hao, C., Gierszewska, M., Swanson, S. K., Kesik-Brodacka, M., Srivastava, S., Florens, L., Washburn, M. P., & Skowronski, J. (2011) · Nature · doi:10.1038/nature10195 · Cited by 1,200
Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production
White, M. J., McArthur, K., Metcalf, D., Lane, R. M., Cambier, J. C., Herold, M. J., van Delft, M. F., Bedoui, S., Lessene, G., Ritchie, M. E., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.036 · Cited by 983
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature
Rice, G. I., Kasher, P. R., Forte, G. M. A., Mannion, N. M., Greenwood, S. M., Szynkiewicz, M., Dickerson, J. E., Bhaskar, S. S., Zampini, M., Briggs, T. A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2414 · Cited by 923
Self-citationImmune Interferon in the Circulation of Patients with Autoimmune Disease
Hooks, J. J., Moutsopoulos, H. M., Geis, S. A., Stahl, N. I., Decker, J. L., & Notkins, A. L. (1979) · New England Journal of Medicine · doi:10.1056/nejm197907053010102 · Cited by 921
Research works printed but not linked: 1
- Krivine, A., Tovey, M., Taty-Taty, R. & Lebon, P. Endogenous interferon-α in newborns from HIV seropositive mothers. J. Interferon Res. 12, S151 (1992).
Cited by
Items 901–931 of 931
Multiomics Approaches to Rheumatic Disease
Kim, H., van Wijk, F., van Loosdregt, J., & Canna, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-11980-4.00005-2
Periodic Fever Syndromes and Other Inherited Autoinflammatory Diseases
Poli, M. C., & Ombrello, A. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-11980-4.00045-3
Vaia, Y., Kim, N., Jeyasingh, S., Sudhakar, S. V., Mankad, K., Biswas, A., Siddiqui, A., Mundy, H. R., Hedderly, T. J., & Singh, R. R. (2026) · Neurological Sciences · doi:10.1007/s10072-026-09147-5
“…with broader imaging findings and systemic features, such as the presence of a positive interferon signature and basal ganglia involvement in AGS [ 10 ], a progeroid phenotype and progressive micro-cephaly in Cockayne syndrome [11], and coarse facies with a cherry red spot in GM1 gangliosidosis.”
Mechanisms outpacing medicine in autoinflammatory diseases
Chen, R. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1868804
“…, SAMHD1 , and ADAR1 enhance IFN-I induction through disturbed nucleic acid metabolism or sensing; STING1 gain-of-function ampli fi es interferon output through constitutive signaling; and USP18 or ISG15 de fi ciency prolongs IFNAR signaling by impairing retro-control (19, 27, 51, 74 – 76).”
MDA5 and the integrated stress response control sex-specific type 1 diabetes onset in NOD micePreprint
Dis, E. S. V., DeGidio, A. T., Yao, L., Winship, D., Sidrauski, C., Gorman, J. A., & Stetson, D. B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.02.736190
“Whereas all of these are essential for disease in the Adar P195A/- mouse model of AGS, we show that development of T1D occurs independently of MDA5, PKR, and ZBP1, and that pharmacological ISR inhibition worsens disease in male NOD mice.”
InfluentialBickerstaff Brainstem Encephalitis in a Pediatric Patient With Aicardi–Goutières Syndrome
Mangold, S., Cartwright, K., Ream, M. A., Rosenberg, N., & Poisson, K. E. (2026) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2026.07.032
A molecular glue induces aberrant STING oligomerization and inhibits autoinflammatory diseases
Zi-wen, F., Zeng, T., Shu, Q., Li, X.-Z., Yu, H., Dai, W., Liu, X., Tian, X.-J., Xu, F., Li, H., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02863-6
Tsujioka, Y., Yamada, Y., Nishimura, G., Kono, T., & Jinzaki, M. (2026) · Pediatrics International · doi:10.1111/ped.70487
Rodriguez, D., & Renaldo, F. (2025) · Elsevier eBooks · doi:10.1016/b978-2-294-78710-2.00068-7
Selective decay of interferon mRNAs controls antiviral immunity and innate memory
Braun, R. M., Ferretti, M., Lee, J. S., Miller, J., Castellana, L., Acuna, J., Whig, K., Dohnalová, L., Descamps, H. C., Huber, A. S., et al. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.07.022 · Cited by 1
Renaudineau, Y., Hawkes, J., Mizgalska, K., Natoli, V., Roachdown, J., Cusin, L., Sposito, F., Sen, E., Kinder, A., Fusaro, M., et al. (2026) · Annals of the Rheumatic Diseases · doi:10.1016/j.ard.2026.07.024
Konak, M., Bozkurt, B., Ceylaner, G., Cüceoğlu, M. K., Özdemir, F. M. A., Kara, B., Duysak, O. S., & Uygun, S. S. (2026) · Pediatric Rheumatology · doi:10.1186/s12969-026-01264-x
Sharma, C., Gothwal, M., Shekhawat, D. S., Yadav, T., Jhirwal, M., Tada, N., Badi, K., Shekhar, S., Singh, P., & Singh, K. (2026) · Clinical Genetics · doi:10.1111/cge.70236
“Such cases challenge the traditional diagnostic model that seeks a single unifying explanation and emphasise that apparently straight-forward infectious or structural causes may coexist with underlying genetic disorders [25, 26].”
C3 Glomerulonephritis in A20 Haploinsufficiency and TREX1 Mutation: A Case Report
Cocchi, V., Raggio, V. E., Patiño, V., Mauvezin, J., Spangenberg, L., Aunchayna, M., Facal, L., Simoes, C., Domínguez, F., Díaz, Á., et al. (2026) · Kidney International Case Reports · doi:10.1016/j.kintcr.2026.100129
Cathepsin L potentiates autoimmunity by inhibiting lysosome-mediated STING degradation
Xing, J., Zhang, Z.-H., Guo, Z.-L., Cai, H., Han, Q., Pan, J., Feng, M.-Y., Xue, W., Zhao, M., Wang, K., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1920873
“SLE is a type I interferonopathy in which elevated IFN drives disease progression (30 – 32).”
The cGAS-STING/MITA pathway in innate antiviral immunity and beyond
Li, F.-X., & Zhong, B. (2026) · Cell Insight · doi:10.1016/j.cellin.2026.100357 · Cited by 1
Nucleic acid sensing pathways in kidney disease development
Andrade-Silva, M., Kang, C., Jang, Y., & Suszták, K. (2026) · Nature Reviews Nephrology · doi:10.1038/s41581-026-01120-x
“Impaired editing by adenosine deaminase acting on RNA 1 (ADAR1) also allows endogenous dsRNAs, including duplexes formed by inverted Alu repeats within transcripts, to activate MDA5–MAVS signalling and provoke autoinflammation 61,62 .”
Saif, M., Husain, A., Sachan, N., & Ahmad, I. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100631
The therapeutic potential of transposable element activity modulation
Morelli, G., D’Onghia, M., Mangiavacchi, A., & Orlando, V. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-026-00528-z
“…syndrome (AGS) is an interferonopathy caused by mutations in genes involved in nucleic acid metabolism and sensing, including TREX1 , RNASEH2A / B / C , SAMHD1 , and ADAR1 , which normally prevent the accumulation of endogenous nucleic acids (Rice et al, 2013; Crow and Manel, 2015).”
The molecular mechanism of irradiation on the growth and development of Tribolium castaneumPreprint
Wu, Y., 张艳宇, Zhou, Z., Feng, L., 袁伯宏, Yang, L., Wu, Y., Guo, K., He, S., Wang, L., et al. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7585101
Cui, J., Shen, Z., Liu, H., Chen, T., Zhang, L., Jiang, J., Yang, L., Wu, D., & Ying, S. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.116057
Monajjemi, M., Mollaamin, F., Haskılıç, Ş. Z., Madak, S. N., Yaman, A., Kabakoz, F. N., Çetinkaya, F. C., Özcan, B., Esenyel, B., Say, K., et al. (2026) · Biointerface Research in Applied Chemistry · doi:10.33263/briac165.128
“This process occurs during DNA replication and simultaneously establishes a barrier that restricts the release of abnormal DNA into the cytosol [55].”
BindingDB Entry 50022888: Cladophorol-A is an inhibitor of cyclic GMP-AMP synthase.
BindingDB (2026) · UC San Diego · doi:10.7270/q2nc662z
BindingDB Entry 50015895: Small molecules targeting cGAS-STING pathway for autoimmune disease.
BindingDB (2023) · UC San Diego · doi:10.7270/q2k35zmg
Understanding ADA2 and the etiology of DADA2: connecting the loose ends
Greiner-Tollersrud, O. K. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1918794
“Greiner-Tollersrud 10.3389/fmed.2026.1918794 Frontiers in Medicine 05 frontiersin.org the prototypical interferonopathy, Aicardi-Goutieres syndrome (AGS), several monogenic defects involved in the nucleic acid metabolism has been added to this disease group (67).”
Influential
Metadata
- Authors
- Crow, Y. J., & Manel, N.
- Affiliations
- Inserm (FR)
- Corresponding author
- Crow, Yanick J.
- Venue
- Nature Reviews Immunology
- Published
- 2015-06-05
- Volume
- 15
- Issue
- 7
- Pages
- 429-440
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1542158376
- Cited by
- 925
- References
- 106
- Citations by year
- 2026: 63 · 2025: 80 · 2024: 83 · 2023: 92 · 2022: 103 · 2021: 92 · 2020: 82 · 2019: 80 · 2018: 71 · 2017: 88 · 2016: 75 · 2015: 16
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-IDEX-0001, ANR-11-LABX-0043)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- Aicardi-Goutières syndrome, type I interferonopathy, type I interferon, innate immune signaling, monogenic disorders, nucleic acid metabolism, innate immune sensors, interferon induction, interferonopathies, treatment options
- MeSH terms
- Animals, Humans, Interferon Type I, Nervous System Malformations, Autoimmune Diseases of the Nervous System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.